BridgeMD
New treatment option for Autism Spectrum Disorder
Official title Heart Rate Informed Changes in Care for Non-Communicating Patients
ClinicalTrials.gov ID: NCT05738278
What this study is testing
- What it's testing
- The overarching aim is to generate knowledge to reduce incidence of pain in non-verbal patients' everyday life. The trial will 1) evaluate how HR can be used to identify potentially painful care procedures that should be re-evaluated in terms of the approach taken; 2) test the effect of heart rate (HR)-informed changes in potentially painful care procedures on biomarkers of pain, and 3) assess how six weeks of communication through HR affects the quality of communication between patient and caregiver.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 70
You may be able to join if
- Between 5 and 70 years of age at the time of data collection
- Autism spectrum disorder as evaluated by clinical psychologist
- Communication difficulties
- Living at a care home with round-the-clock staff for at least five days a week; or attending one-to-one staffed school/day-care at least five days a...
- Written informed consent is obtained from the people' legal representative.
You likely can't join if
- \- Having any autoimmune disorder or any type of cancer with ongoing chemotherapy.
The study team makes the final eligibility decision.
Where it's taking place
- Oslo, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oslo, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.